GlaxoSmithKline pharma Q1 result

GlaxoSmithKline pharma Q1 result
On Friday,GlaxoSmithKline Pharmaceuticals announced its audited financial results for the quarter ending March 31, 2011. The company recorded a net profit of Rs. 46 lakh for the quarter as compared to net profit of Rs. 16,119lakh reported during the corresponding period in 2010.

Net sales of the company during the quarter ending March 31, 2011 stood at Rs. 60,290 lakh, as compared to Rs. 54,110 lakh for corresponding quarter of 2010, i.e. a growth of 11 per cent for fourth quarter.

Moreover, the EPS of the company (after exceptional items) during quarter, decreased to Rs. 0.1 as against Rs. 19.00 in the year ago period of 2010. The decline in net profit and EPS was due to the inclusion of exceptional items (net of tax), which stood at Rs. 18,587 lakh and brought the net profit to Rs 46 lakh.

The net profit after tax before exceptional items was Rs. 18,633 lakh in comparison to Rs. 16,119 lakh in the corresponding period of the previous fiscal.

On Friday at 3:15 P.M IST, on the Bombay Stock Exchange (BSE), stocks of the firm were trading at Rs. 2,282.00, up by 1.66 per cent or by Rs. 37.25. The stock had seen an intraday high of Rs 2,322.75 and a low of Rs. 2195.30, till then.

Read more about: results, gsk pharma, pharma, bse
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?